Help us answer some intriguing questions about the effect of stress on ulcerative colitis symptoms. Dr. Emeran A. Mayer, director of the G. Oppenheimer Center for Neurobiology of Stress and Resilience (CNSR), Dr. Jenny Sauk, clinical director of the Center for Inflammatory Bowel Diseases, and Dr. Jonathan P. Jacobs, director of the Jacobs Laboratory, are conducting the UC Longitudinal Study to identify novel brain-gut-microbiome pathways that cause symptoms in IBD patients. This research study is to improve our understanding of IBD and its underlying cause.
We will use magnetic resonance imaging (MRI) to observe differences in the brain between people diagnosed with UC compared to healthy controls. We will also collect other measures such as thermal sensitivity and blood and stool samples, to be able to make biological connections associated with the subject groups. By doing this study, we hope to enhance our knowledge on IBD in order to keep the field moving in the right direction and becoming one step closer to discovering effective treatments.
Participants must be:
Compensation:
For further details please call Miriam Dvorsky at 310-206-3778 or mdvorsky@mednet.ucla.edu or Hyo Jin Ryu at 310-825-7206.
UCLA IRB Approved IRB# 18-000470 Committee: Medical IRB 3 Approval Date: 4/25/2018 through 3/4/2020
The purpose of this registry study is to learn more about IBD, how doctors treat IBD, how well medications and other treatments work, the safety of those treatments, and to improve the care and outcomes of people with IBD. Approximately 1,000 men and women ages 18 years and older with a diagnosis of IBD in the U.S. are expected to participate in the first year with no defined upper limit on total enrollment after year one. Non-interventional Corrona Registry research programs are coordinated efforts to collect information directly from physicians and patients with IBD. Findings from Corrona Registries will help providers improve the treatment options for these health conditions.
Participants must be:
Compensation:
This study is conducted by Dr. Jenny Sauk with the Center for Inflammatory Bowel Diseases. For further details please call Miriam Dvorsky at 310-206-3778 or mdvorsky@mednet.ucla.edu
UCLA IRB Approved IRB# 17-001324 Approval Date: 3/13/2019 through 7/8/2019
Do you suffer from abdominal pain, constipation, and/or diarrhea? Have you ever been told you have irritable bowel syndrome (IBS)? If so, and you are 18 years or older, you may qualify to participate in a UCLA research study that involves free nutrition sessions with a skilled IBS-specializing dietitian.
If so, we invite you to participate in brain imaging research at the G. Oppenheimer Center for Neurobiology of Stress and Resilience.
To participate, you must be:
This study is conducted by Lin Chang, MD, G. Oppenheimer Center for Neurobiology of Stress and Resilience.
If interested, please contact Rubi Arias at 310-794-0345 or rubiarias@mednet.ucla.edu
Protocol ID: IRB #10-000934 UCLA IRB Approval Date: 7/11/2018 through 7/10/2019 Committee: Medical IRB 1
Do you suffer from abdominal pain, constipation and/or diarrhea? Have you ever been told that you have irritable bowel syndrome or IBS? If so, you may qualify to participate in a research study involving a treatment program designed to target stress in patients with irritable bowel syndrome (IBS).
To participate, you must be:
Eligible participants will:
Compensation:
This study is conducted by Lin Chang, MD, G. Oppenheimer Center for Neurobiology of Stress and Resilience. If interested, please contact Rubi Arias at 310-794-0345 or rubiarias@mednet.ucla.edu
*Please note that confidentiality of emails cannot be guaranteed. Do not include sensitive information in your email if you choose to contact us by that method.
Protocol ID:IRB#18-000235 UCLA IRB Approved Approval Date: 7/17/2018 Through: 2/27/2019 Committee: Medical IRB 1
Cholangioscopy is an endoscopic technique used for direct visualization of the bile ducts. The new FDA approved digital Spyglass system introduced a digital sensor for better image quality, which will allow for better visualization and diagnosis. If you are a male or female >18 years old referred for the evaluation of biliary strictures (narrowing) or removal of difficult stones, you might be eligible to participate in the study. You must be undergoing ERCP along with DS Spyglass cholangioscopy as part of your clinical care at UCLA. The study will evaluate the clinical safety, feasibility and efficacy of the new Spyglass DS Spyglass cholangioscopy system for diagnostic imaging of biliary tract disorders (particularly those with biliary strictures and stones).
Inclusion/Exclusion Criteria:
This study is conducted by Dr. V. Raman Muthusamy. The study is coordinated by Amanda Moralde.
If interested, please call 310-267-3636.
Protocol ID: IRB# 16-000341 Approval Date: 3/16/2016 through 2/21/2019 Committee: Medical IRB 1
